The markets traded higher during the midday with the Dow gaining 37 points to 14,009 on positive earnings reports. Nasdaq eased a point to 3190.
On the upside
Masco (NYSE: MAS) narrowed fourth quarter losses more than expected as revenue climbed.
Ziopharm (Nasdaq: ZIOP) reached the target number of progression-free survival events for a Phase 3 trial of palifosfamide.
Seeking Alpha listed Keryx Biopharmaceuticals (NYSE: KERX) as the best performing Russell 3000 stock in 2013.
On the downside
Valspar (NYSE: VAL) reported lower first quarter revenue and earnings that fell short of analyst expectations.
MELA Sciences (Nasdaq: MELA) priced its public offering of 6.1 million common shares at the discounted price of $1.30 per share.
Seeking Alpha wrote that Celsion (Nasdaq: CLSN) was worthless.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 index rose 2 points to 1519.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here